Sanger Institute: Landmark study shows AML is at least 11 different diseases

(Wellcome Trust Sanger Institute) Patients with acute myeloid leukemia (AML) could be separated genomically into at least 11 major groups, each with different constellations of genetic changes and distinctive clinical features. This genetic complexity helps explain why AML shows such variability in survival rates among patients. Full knowledge of the genetic make-up of a patient's leukemia substantially improved the ability to predict whether that patient would be cured with current treatments.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news